admin | May 3, 2021
The California Institute for Regenerative Medicine has awarded a group of researchers $20 million for work on six compounds. Recipients are tasked with developing drugs for clinical trials within the next four years. We at the MPD Foundation are excited about this new development and investment in research that could help MPD patients.
Click here for the full article from the San-Diego Union Tribune